DIN 02540215 — IMBRUVICA 70 MG
IMBRUVICA is a suspension of Ibrutinib marketed by JANSSEN INC. The full Ibrutinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02540215
- Brand name
- IMBRUVICA
- Active ingredient
- Ibrutinib
- Strength
- 70 MG
- Dosage form
- SUSPENSION
- Route
- ORAL
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Bruton's tyrosine kinase (BTK) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ibrutinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02434407 | IMBRUVICA | 140 MG | CAPSULE | JANSSEN INC | MARKETED |